Alvimopan and Ileus in PSF

Completed · Not applicable · Has a placebo group

Conditions studied: Ileus, Spinal Fusion

In brief

The purpose of the study is to determine with Alvimopan reduces the incidence of post operative ileus in patients who undergo posterior spinal fusion.

Key facts

Study ID

NCT02218190

Run by

Washington University School of Medicine

People needed

31

Starts

2014-08-01

Expected to finish

2019-01-01

Last updated by the study team

2019-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients undergoing elective PSF of at least 5 levels and/or fixation to pelvis

You may not qualify if…

• pregnant women
• ischemic heart disease
• chronic liver or renal disease
• prior bowel resection
• presence of colostomy or ileostomy
• gastroparesis
• complete bowel obstruction
• inflammatory bowel disease (ulcerative colitis or Crohn's disease).

Where it is running

• Barnes Jewish Hospital / Washington University in St. Louis School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.